Floatz logo

Remegal

Complex Partial Seizures

ValexfarmPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Complex Partial Seizures cohort.

Asset / SponsorPhaseRating
Rwj-333369
SK Life Science, Inc.
Phase 3BB
Carisbamate
SK Life Science, Inc.
Phase 3BB
Vigabatrin
University of Pennsylvania
Phase 4B

Same molecule, other indications

Remegal is also rated in:

epilepsyDormant
B
Indicative ·
57 / 100
View asset →
simple partial epilepsyDormant
NR
Indicative ·
/ 100
View asset →
focal epilepsyDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →